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ABSTRACT 23 
 The Nairoviridae family of the Bunyavirales order comprises tick-borne tri-segmented 24 
negative strand RNA viruses, with several members associated with serious or fatal disease 25 
in humans and animals. A notable member is Crimean-Congo hemorrhagic fever virus 26 
(CCHFV), which is the most widely-distributed tick-borne pathogen, and associated with 27 
devastating human disease with case/fatality rates averaging 30%. Hazara virus (HAZV) is 28 
closely-related to CCHFV, sharing the same serogroup and many structural, biochemical and 29 
cellular properties. To improve understanding of HAZV and nairovirus multiplication cycles, 30 
we developed for the first time a rescue system permitting efficient recovery of infectious HAZV 31 
from cDNA. This system now allows reverse genetics analysis of nairoviruses without the need 32 
for high biosafety containment, as is required for CCHFV. We used this system to test the 33 
importance of a DQVD caspase cleavage site exposed on the apex of the HAZV nucleocapsid 34 
protein arm domain that is cleaved during HAZV infection, and for which the equivalent DEVD 35 
sequence was recently shown to be important for CCHFV growth in tick but not mammalian 36 
cells. Infectious HAZV bearing an un-cleavable DQVE sequence was rescued and exhibited 37 
equivalent growth parameters to wild-type in both mammalian and tick cells, showing this site 38 
was dispensable for virus multiplication. In contrast, substitution of the DQVD motif with the 39 
similarly un-cleavable AQVA sequence could not be rescued despite repeated efforts. 40 
Together, this work highlights the importance of this caspase cleavage site in the HAZV 41 
lifecycle, but reveals the DQVD sequence performs a critical role aside from caspase 42 
cleavage.  43 
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IMPORTANCE 45 
Hazara virus is classified within the Nairoviridae family along with Crimean-Congo 46 
hemorrhagic fever virus (CCHFV), which is one of the most lethal human pathogens in 47 
existence, requiring the highest biosafety level (BSL) containment (BSL-4). In contrast, HAZV 48 
is not associated with human disease and thus can be studied using less-restrictive BSL-2 49 
protocols. Here, we report a system able to rescue Hazara virus (HAZV) from cDNAs, thus 50 
permitting reverse genetic interrogation of the HAZV replication cycle. We used this system to 51 
examine the role of a caspase cleavage site, DQVD, within the HAZV nucleocapsid protein 52 
that is also conserved in CCHFV. By engineering mutant viruses, we showed caspase 53 
cleavage at this site was not required for productive infection, and furthermore that this 54 
sequence performs a critical role in the virus lifecycle aside from caspase cleavage. This 55 
system will accelerate nairovirus research due to its efficiency and utility under amenable BSL-56 
2 protocols. 57 
  58 
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INTRODUCTION 59 
 The Bunyavirales order comprises over 500 RNA viruses that are the causative agents 60 
of infection and disease across a broad range of hosts that encompasses insects, plants, 61 
animals and humans. The bunyavirus genome comprises between 2 and 8 segments of 62 
negative sense RNA, with some species utilizing an ambisense coding strategy for one or 63 
more of their segments [1]. The recent use of metagenomic techniques [2], [3], [4] has led to 64 
the discovery of many new diverse bunyaviruses, particularly from within arthropod hosts, and 65 
so bunyavirus classification is in a state of flux. Currently, the order is divided into twelve 66 
families [1], and viruses associated with human infections are classified within five of these, 67 
namely the Arenaviridae, Hantaviridae, Nairoviridae, Peribunyaviridae and Phenuiviridae 68 
families. The Nairoviridae family comprises tick-borne tri-segmented RNA viruses, with 69 
several members associated with serious and fatal disease in both humans and animals. 70 
Nairobi sheep disease virus, after which the family was named, causes acute gastroenteritis 71 
in susceptible populations of sheep and goats, with an associated mortality rate of 90%, 72 
resulting in significant economic impact [5]. Crimean-Congo hemorrhagic fever virus (CCHFV) 73 
is the most widely distributed tick-borne pathogen on earth [6], and is associated with a 74 
devastating human disease known as Crimean-Congo hemorrhagic fever (CCHF) with 75 
case/fatality rates averaging 30%, but rising as high as 80% in specific outbreaks [7], [8]. 76 
CCHF most commonly results from the bite of a CCHFV-infected tick of the Hyalomma 77 
species, which is widespread within Africa, South-East Europe and Asia, and concerns are 78 
growing over the widening habitat of permissive tick vectors in the face of global warming [9]–79 
[12]. Due to the associated risks, CCHFV is one of a select group of pathogens classified 80 
within hazard group 4, requiring the highest level of biological containment for its propagation 81 
(biosafety level 4; BSL-4), which has restricted research activity and hindered progress in 82 
elucidating the molecular and cellular biology of CCHFV, as well as nairoviruses in general. 83 
 Hazara virus (HAZV) is a nairovirus that is closely related to CCHFV, such that it is 84 
included within the same serogroup [1], however, it is non-pathogenic in humans. As a 85 
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consequence, HAZV can be studied in relatively accessible BSL-2 facilities, which permits 86 
more rapid and cost-effective research.  87 
 The genomes of HAZV and CCHFV are tri-segmented, comprising small (S), medium 88 
(M) and large (L) segments. The S segment of both viruses encodes the nucleoprotein (N), 89 
which encapsidates the RNA segments through its RNA binding ability. In addition, the 90 
CCHFV S segment is thought to express an additional non-structural protein (NSs) using an 91 
ambi-sense transcription strategy, with a role in apoptotic activation [13]. The M segment 92 
encodes the glycoprotein precursor GPC that is subsequently cleaved into the structural 93 
glycoproteins Gn and Gc, and additional non-structural glycoproteins, whereas the L segment 94 
encodes the relatively large RNA-dependent RNA polymerase (RdRp) [14], which is involved 95 
in replication and transcription of viral RNA, but also encodes an N terminal ovarian tumour 96 
(OTU) domain with roles in mitigating host cell innate immunity [15]. 97 
 We and others recently solved the crystal structure of the N protein of both HAZV and 98 
CCHFV, which revealed the location of a conserved caspase-3 cleavage (C3C) site on the 99 
exposed apex of the extended arm domain suggestive of an important role at some stage of 100 
the nairovirus multiplication cycle [16]–[19]. One possibility was that the C3C site acted as a 101 
caspase-3 decoy, diverting caspase-3 away from its native cellular substrates and thus 102 
preventing or prolonging apoptosis activation, as has recently been found for the related Junin 103 
arenavirus (JUNV) [20]. In support of this, both CCHFV and HAZV-N proteins are extensively 104 
cleaved at their C3C sites in mammalian cells, with apoptosis induced relatively late in infection 105 
[21],[22]. However, during infection by both HAZV and CCHFV in tick cell lines, the C3C site 106 
is subjected to little or no cleavage, revealing a fundamental difference in the tick and 107 
mammalian cellular response to nairovirus infection [23],[22]. Recently, a system capable of 108 
rescuing infectious CCHFV from cDNA was used to show that the conserved C3C site on the 109 
arm apex was dispensable for infection in mammalian cells, but strikingly mutation of this motif 110 
resulted in a significant drop in replication ability during infection of cells of tick origin [23]. 111 
Taken together, these findings revealed a critical role for the C3C site for CCHFV growth in 112 
ticks, although whether the C3C site in HAZV was required remained unknown. 113 
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 Here, we developed a system for the rescue of infectious HAZV to authentically-test 114 
the importance of caspase cleavage of HAZV-N during infection. By generating a panel of 115 
mutant viruses in which the arm domain DQVD was rendered un-cleavable, we showed while 116 
this sequence was critical for virus viability, it was not to allow caspase cleavage. Instead, our 117 
results show that the DQVD site performs a critical role in the virus life cycle aside from acting 118 
as a caspase substrate. To the best of our knowledge, this work represents the first recovery 119 
of recombinant HAZV (rHAZV) and also the first nairovirus rescue system that permits virus 120 
rescue in BSL-2 facilities, thus facilitating rapid future gains in the understanding of this 121 
important group of viruses.  122 
 123 
  124 
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RESULTS 125 
Characterization of the DQVD caspase cleavage site in HAZV-N. In previous work, 126 
we identified a number of HAZV-N specific cleavage products during low-MOI infection of 127 
mammalian cells [22]. To further characterise these bands, we repeated HAZV infection of 128 
human-origin SW13 cells at a higher MOI of 1.0 to increase presence of these cleaved forms 129 
of HAZV-N thereby facilitating detection via western blotting. HAZV-N antisera detected 130 
prominent N-specific cleavage products with apparent molecular masses of approximately 30 131 
and 22 kDa, and exhibiting a temporal expression pattern, being absent during initial stages 132 
of infection, and most abundant at later time points (Fig 1A). Previous work by ourselves and 133 
others [16], [19] established that the generation of 30 and 22 kDa products resulted from 134 
caspase-3 cleavage of HAZV-N at a consensus DQVD motif (Fig 1B) located at the apex of 135 
the HAZV-N arm domain (Fig 1C). The HAZV-N arm domain also possesses the sequence 136 
ENKD, which partially-conforms to the caspase-3 cleavage consensus sequence, and is 137 
immediately upstream of the DQVD such that these sites overlap forming the sequence 138 
ENKDQVD. 139 
 140 
Recovery of recombinant HAZV. In order to investigate the role of the ENKD/DQVD 141 
caspase cleavage motifs in the authentic context of HAZV infection, we generated a cDNA-142 
based system to allow rescue of infectious HAZV. This system comprised three cDNA 143 
plasmids that were designed to transcribe the anti-genomic cRNA strands of the HAZV S, M 144 
and L segments under the control of the bacteriophage T7 RNA polymerase promoter, an 145 
approach that has been used by others to rescue bunyaviruses of the Arenaviridae, 146 
Peribunyaviridae and Phenuiviridae families, as well as CCHFV from the Nairoviridae family 147 
[24]–[27]. The three corresponding plasmids pMK-RQ-S, pMK-RQ-M and pMK-RQ-L were co-148 
transfected into BSR-T7 cells expressing T7 RNA polymerase, along with plasmid pCAG-149 
T7pol, which allows increased expression of the T7 RNA polymerase, and in our hands further 150 
increases the efficiency of virus recovery (Fig 2A). Additional transfections in which HAZV L 151 
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segment expression plasmid pMK-RQ-L was omitted were also performed, to act as rescue 152 
controls incapable of generating infectious virus. 153 
 In cells transfected with all four plasmids (‘complete transfection’), HAZV-N protein 154 
was abundantly detected by western blotting in the primary transfected cultures at 120 hours 155 
post transfection (p.Tr) (Fig 2B; p.Tr , lane 1) suggestive of HAZV rescue. As confirmation, 156 
supernatants of primary transfected cultures at 72-, 96- and 120-hours p.Tr were harvested 157 
and used to infect further SW13 cells in order to amplify any rescued viruses. At 48-hours post 158 
infection (p.Inf) SW13 cell lysates were harvested and tested for presence of HAZV-N by 159 
western blot analysis, which revealed abundant N production in 96- and 120-hours p.Inf 160 
samples, confirming virus amplification had occurred (Fig 2B; p.Inf, lanes 2-4). Rescue of WT 161 
rHAZV was achieved in all attempts using this optimized protocol, indicating the system was 162 
robust and efficient. 163 
 In contrast, HAZV-N protein was not detected in control transfected cells that received 164 
no pMK-RQ-L (‘control transfection’) in primary transfected cells (Fig 2B; p.Tr , lane 5), and 165 
correspondingly, no N was detected in cell lysates harvested at any time points in the p.Inf 166 
wells (Fig 2B; p.Inf, lanes 6-8). 167 
 To examine the efficiency of HAZV rescue, supernatant samples taken from primary 168 
transfected BSR-T7 cells at 72-, 96- and 120-hours p.Tr time points were used to set up plaque 169 
assays in SW13 cells. Analysis of the resulting plaques formed showed increasing titres of 170 
rHAZV in the p.Tr supernatant increasing through 72-, 96- and 120-hours p.Tr time points (Fig 171 
2C), with titres of rescued virus reaching over 1.2x105 pfu/ml in the 120-hours p.Tr 172 
supernatants.   173 
 174 
 Comparison of HAZV and rHAZV growth kinetics. Although the rescued virus was 175 
generated from a cDNA source corresponding precisely to HAZV strain JC280, we wanted to 176 
verify that rHAZV displayed equivalent growth properties to the parental JC280 isolate, which 177 
may have acquired cell culture adaptations through multiple rounds of propagation. To achieve 178 
this, we compared multi-step growth kinetics of rHAZV alongside the parental virus isolate and 179 
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mock-infected controls. Following infection at an MOI of 0.001, supernatant samples from 180 
each infection scenario were harvested every 24 hours for up to 96 hours p.Inf, and used to 181 
titre infectious virus by plaque assay (Fig 3A). Similar titres for HAZV and rHAZV were 182 
observed at all time points, indicating infectious rHAZV displayed equivalent growth kinetics 183 
to the parental virus. Plaque morphology of rHAZV also resembled that of the parental virus 184 
(Fig 3B), providing further evidence that recombinant and parental viruses possessed 185 
indistinguishable growth properties. 186 
 187 
 Confirmation of HAZV rescue from a cDNA source by incorporation of a silent 188 
mutation. To confirm the recombinant source of rHAZV as cDNA, a single nucleotide change 189 
of G723T in the N protein open reading frame (ORF) was engineered into pMK-RQ-S to create 190 
pMK-RQ-S(G723T). This change was silent at the amino acid level, but generated a Hind III 191 
recognition site in the corresponding cDNA sequence (Fig 4A). Plasmid pMK-RQ-S(G723T) 192 
replaced the corresponding WT pMK-RQ-S plasmid in a HAZV recovery experiment alongside 193 
WT rescue plasmids pMK-RQ-M, pMK-RQ-L, and pCAG-T7pol, described above, and western 194 
blotting of post-infection lysates revealed the abundant presence of HAZV-N indicating 195 
successful mutant virus recovery (Fig 4B). To verify incorporation of the G723T change, RNA 196 
extracted from rHAZV and rHAZV(G723T) infected SW13 cell supernatants was used as a 197 
template for RT-PCR amplification, using primers designed to yield an 802 nucleotide-long 198 
cDNA fragment encompassing the Hind III site. While the WT cDNA fragment was un-cleaved 199 
by Hind III, the corresponding fragment from rHAZV(G723T) was cleaved to generate two 200 
products with lengths of approximately 300 and 500 bp (Fig 4C and 4D), corresponding to the 201 
fragments expected following Hind III digestion. To confirm that the amplified PCR fragment 202 
was templated from a cDNA that originated from an RNA source rather than plasmid carried 203 
over from the transfections, we also performed control PCR amplifications without prior RT 204 
treatment, and these failed to yield a DNA fragment (Fig 4D). Successful rescue of this rHAZV 205 
variant was also confirmed by sequencing of the RT-PCR fragment bearing the introduced 206 
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Hind III recognition site. Taken together, these findings confirm the utility of the rescue system 207 
to efficiently generate both WT and mutant rHAZV variants. 208 
 209 
 Rescue of infectious HAZV variants with alterations to caspase cleavage sites 210 
on the N protein arm apex. Previous work from ourselves and others has identified caspase-211 
3 cleavage motifs on both the CCHFV N (DEVD) and the HAZV-N (DQVD) proteins at the 212 
apex of their respective arm domains [16], [17], [19] and mapping these sites onto the 213 
corresponding crystal structures show these are in precisely superimposable positions (Fig 214 
5A). Both sites also are preceded by sequences that partially-conform to caspase cleavage 215 
consensus sequences suggesting that their cleavage is possible, but nevertheless unlikely. 216 
These sequences are KHKD in CCHFV and ENKD in HAZV, and both sites overlap the 217 
established DEVD/DQVD cleavage sites at a critical aspartic acid reside (D) (Fig 5A). Both 218 
DEVD and DQVD sites are known to be cleaved during infection of mammalian cells by 219 
CCHFV and HAZV, respectively [22], [21], and a mutant CCHFV with the DEVD site changed 220 
to the non-cleavable AEVA site was shown to be severely growth-attenuated in tick cells, but 221 
phenotypically-silent when growth in cells of mammalian origin [23].  222 
 To investigate the importance of the DQVD and overlapping ENKD motifs in the 223 
context of HAZV infection (Fig 1A and 5A), we created mutant plasmids designed to express 224 
HAZV S segments in which the ENKD and DQVD motifs within the N ORF were individually 225 
perturbed by mutation. The aspartic acid (D) residues at position 1 within these motifs 226 
(underlined) are known to be critical for caspase recognition and cleavage [28], and so in both 227 
cases, this residue was changed to glutamic acid (E) to generate the non-cleavable 228 
sequences ENKE and DQVE. An additional double mutant plasmid with the sequence AQVA 229 
was also generated, concurrently rendering both ENKD and DQVD motifs as un-cleavable, 230 
and allowing direct comparison with the AEVA mutant generated for CCHFV, described above 231 
[23]. 232 
 As with the rHAZV recoveries described above, the plasmid expressing the WT HAZV 233 
S segment pMK-RQ-S, or its mutant derivatives (named correspondingly DQVE, ENKE or 234 
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AQVA) were transfected into BSR-T7 cells along with pMK-RQ-M, pMK-RQ-L, and pCAG-235 
T7pol, and at 72-, 96- and 120-hours p.Tr supernatants were collected and used to re-infect 236 
fresh SW13 monolayers for 48 hours. At this time point, lysates were collected and examined 237 
for HAZV-N expression via western blotting with anti-HAZV-N antisera (Fig 5A) with HAZV-N 238 
detection in virus rescue wells indicating successful recovery of both recombinant WT and 239 
mutant viruses. Successful rescue was achieved for HAZV-N mutants rHAZV-DQVE and 240 
rHAZV-ENKE, with rescue confirmed by sequencing of an RT-PCR fragment bearing the 241 
altered cleavage sites (data not shown) amplified from viral RNA harvested from p.Inf 242 
supernatants. In contrast, double mutant rHAZV-AQVA could not be rescued, as evidenced 243 
by three failed rescue attempts alongside consistent successful rescue of WT rHAZV.  244 
 The growth kinetics of rescued rHAZV-ENKE and rHAZV-DQVE were examined 245 
alongside WT rHAZV via plaque assay over a 4-day time course (Fig 5B), and morphology of 246 
resulting plaques was assessed (Fig 5C). Viral titres at all time points tested showed no 247 
significant differences between WT rHAZV and the rHAZV-ENKE or rHAZV-DQVE mutants 248 
(Fig 5D) and taken together these results show that abrogating caspase cleavage at either of 249 
these sites has no detectable effect on virus fitness. 250 
 251 
 The HAZV-N DQVD caspase cleavage motif is required for rescue of infectious 252 
virus, but for reasons other than caspase cleavage. The results of the previous section 253 
showed HAZV mutants bearing un-cleavable DQVE and ENKE sequences in N could be 254 
rescued, whereas an AQVA mutant could not. As expected, abrogation of cleavage at the 255 
DQVD site coincided with loss of the customary 30 kDa HAZV-N cleavage product, as 256 
measured by western blot analysis (Fig 5E). Interestingly, this band was replaced by a band 257 
of increased apparent mass, corresponding to approximately 32 kDa. This 32 kDa HAZV-N 258 
fragment is too large to correspond to alternative cleavage at the adjacent and overlapping 259 
ENKD, so our results show that during infection with the rHAZV-DQVE mutant, N cleavage at 260 
neither the overlapping ENKD site, nor the altered DQVE site, occurs. The fact that infection 261 
with the DQVE mutant does not result in generation of a 30 kDa fragment also shows the 262 
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ENKD site is not a substrate for caspase cleavage even when the DQVD site can no longer 263 
be cleaved, consistent with its only partial similarity to the caspase cleavage consensus. 264 
Taken together, these results show that HAZV-N lacking a functional caspase cleavage site 265 
at the arm apex can be rescued as infectious virus, and thus a caspase cleavable site at the 266 
arm apex is not a prerequisite for HAZV viability. 267 
 Thus, our results show that individually, the DQVD and ENKD motifs are dispensable 268 
for the HAZV life-cycle in cultured mammalian cells. However, our observation that the double 269 
mutant AQVA could not be rescued despite repeated attempts suggests that simultaneous 270 
alteration of both sites critically-prevents virus multiplication at some stage of the life cycle. As 271 
we show above that cleavage within the arm domain is not required for virus viability, we 272 
suggest the fatal deficiency of the AQVA mutant relates to a function other than caspase 273 
cleavability. 274 
  This observation is interesting in comparison to the previous findings for CCHFV that 275 
the corresponding AEVA mutant, which also acts as a double mutant knocking out both KHKD 276 
and DEVD sites, could be rescued as infectious virus, and furthermore replicated to wild-type 277 
(WT) titres in mammalian cells  [23]. Taken together, these findings suggest that sequences 278 
within the arm apex of CCHFV and HAZV perform different roles, with those of HAZV being 279 
highly sensitive to change, with those of CCHFV being more tolerant. 280 
 281 
 The DQVD caspase-3 cleavage motif is also dispensable for HAZV replication in 282 
cells of tick origin. As described above, previous work by others has shown that a CCHFV 283 
variant with an un-cleavable AEVA substitution at the N protein arm apex DEVD site replicates 284 
to WT titres in SW13 cells, but cannot replicate in tick cells, suggesting a critical role for this 285 
motif in the CCHFV life cycle [23]. Having shown that mutations at caspase cleavage sites 286 
ENKD or DQVD at this location on HAZV-N pose no significant reduction in growth in 287 
mammalian cells (Fig 5C), we next wanted to examine the role of these motifs for replication 288 
in tick cells. 289 
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 To achieve this aim, we examined the ability of the rHAZV-DQVE and rHAZV-ENKE 290 
variants to multiply in CTVM/HAE9 tick cells, as determined by their ability to express 291 
abundant HAZV-N after 48 hours (Fig 6A). Infection with rHAZV carrying individual DQVE and 292 
ENKE substitutions resulted in the synthesis of equivalent quantities of N as WT rHAZV, as 293 
measured by western blot analysis with HAZV-N antisera, categorically showing that the 294 
corresponding DQVD and ENKD motifs are non-essential for rHAZV replication in cells of tick 295 
origin, when individually altered. The equivalent abundance of N proteins expressed by these 296 
viruses compared to WT also suggested these viruses were not growth attenuated in these 297 
cells. 298 
 A more direct comparison between the role of the arm apex cleavage sites of CCHFV 299 
and HAZV would be achieved using equivalent substituting sequences; AEVA for CCHFV and 300 
AQVA for HAZV. However, this comparison was not possible, as the AQVA mutant for HAZV 301 
could not be rescued, despite repeated efforts. Nevertheless, these results show the ability of 302 
the DQVE virus to replicate in tick cells does not require a cleavable caspase site on the apex 303 
of the N arm domain. 304 
  305 
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DISCUSSION 306 
 Here, we report a rescue system allowing the production of infectious HAZV from 307 
cDNA that can be utilized in widespread and amenable BSL-2 facilities, and which represents 308 
an important advance in the study of nairovirus molecular and cellular biology. Previously, a 309 
rescue system for the highly-pathogenic CCHFV was established, permitting insight into the 310 
role of multiple nairovirus specific features such as the OTU domain within the L protein ORF, 311 
as well as characterization of the processing pathway of GPC, expressed from the M segment 312 
ORF [15], [27]. However, due to the extreme pathogenicity of CCHFV, utilization of this rescue 313 
system has been restricted to a small number of laboratories that can comply with the highest 314 
BSL-4 containment protocols. The development of a HAZV rescue system that can be utilized 315 
using less-restrictive BSL-2 protocols will greatly facilitate and accelerate future nairovirus 316 
research. A HAZV mini-genome system has also been reported recently [29], which allowed 317 
the delineation and characterization of the viral mRNA transcription promoters, and while utility 318 
of this system is restricted to analysis of cis-acting signals involved in RNA synthesis, it will 319 
also allow a rapid accumulation of information regarding nairovirus multiplication. 320 
 The HAZV rescue system we describe here was capable of generating a titre of WT 321 
HAZV of over 1.2 x 105 pfu/ml in primary transfection supernatants. Correspondingly, rescue 322 
of WT rHAZV was successful in every attempt, and allowed rescue of each of the mutants 323 
described in this manuscript with minimal experimental replicates. Taken together these 324 
findings suggest the HAZV rescue system is highly efficient, a property that will facilitate the 325 
rescue of mutant viruses that possess other attenuating lesions. 326 
 The N proteins of both HAZV and CCHFV possess caspase-3 cleavage motifs with the 327 
sequences DQVD and DEVD, respectively [16], [30], prominently located at equivalent 328 
positions on the apex of their arm domains, suggesting their conservation is driven by 329 
functional importance. In line with this suggestion, previous work has shown both HAZV and 330 
CCHFV N proteins are cleaved in vitro at these motifs by purified active caspase-3 [16], [17], 331 
[19], as well as by caspase-3 in cultured human cells [22]. 332 
 333 
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 To test the importance of cleavage within the HAZV-N arm domain during HAZV 334 
infection, we generated mutant viruses for which the overlapping ENKD and DQVD consensus 335 
cleavage sites were individually disrupted with glutamic acid substitutions at position 1 336 
(underlined) to render them un-cleavable. The fact that both the resulting viruses rHAZV-337 
ENKE and rHAZV-DQVE were viable and replicated with growth kinetics that were 338 
indistinguishable from WT rHAZV is a critical observation. Because the DQVE mutant is 339 
cleaved at neither this DQVE site, nor the adjacent ENKD site (Fig 5C), these findings show 340 
cleavage within the arm apex is not a requirement for virus viability. 341 
 Our failure to rescue the rHAZV-AQVA mutant despite repeated efforts suggests it is 342 
deficient in a critical function. We show that caspase cleavage within the arm apex is not a 343 
requirement for virus viability, and indeed viruses that cannot be cleaved at this location show 344 
equivalent fitness to WT HAZV. Thus, the lack of rescue of rHAZV-AQVD cannot be due to 345 
loss of cleavability of the arm apex. This finding is intriguing in light of recent work with CCHFV 346 
for which the equivalent AEVA mutant was found to be phenotypically-silent in mammalian 347 
cells but significantly reduced in fitness for replication in tick cells. These findings suggest the 348 
requirements for HAZV and CCHFV are different, and the molecular basis for these 349 
differences likely lie in the subtle differences of arm domain sequences (Figure 5A). Our 350 
results here show the DQVD site is important for rescue, but not for caspase cleavage and 351 
this provides a starting point for studies to elucidate the critical role of this DQVD motif. So 352 
what might this possible role be? One possibility is in N-N multimerization. Previous work has 353 
shown the crystallographic N-N interface between adjacent monomers involves the formation 354 
of a hydrophobic pocket comprising six residues from the arm domain of one monomer that 355 
interacts with a single proline reside located on the base of the globular domain of the adjacent 356 
monomer [16]. Interestingly, neither aspartate (D) residues within the DQVD motif that are 357 
altered in either DQVE or AQVA mutants are involved in this interaction, which would thus 358 
appear to rule out N-N interactions as its critical role. However, we cannot rule out the 359 
possibility that the HAZV N-N interaction that occurs in the assembly of an authentic nairovirus 360 
ribonucleoprotein (RNP) is different to that revealed in the HAZV N crystal structure, and that 361 
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these critical aspartate residues do indeed play important roles in RNP formation. This matter 362 
will be resolved by solving the structure of nairovirus RNPs in their native state. An alternative 363 
possibility is that the DQVD site is involved in an interaction with a host factor, and the 364 
availability of such a component may also explain the differential outcome of infection with 365 
CCHFV in mammalian and tick cells. 366 
 Previous work by ourselves and others has suggested that caspase cleavage of the 367 
nairovirus N protein may act as a caspase decoy, as has been shown for JUNV. Our results 368 
presented here showing the essential role of the HAZV DQVD motif is essential for a role other 369 
than cleavage does not rule this out. In fact, the finding that the rHAZV-DQVE mutant no 370 
longer generates the customary 30 kDa band, but instead is cleaved to yield a 32 kDa product 371 
shows that alternative cleavage sites exist that are amenable to cleavage once the dominant 372 
sites are removed. Deciphering the caspase cleavage profile of nairovirus N proteins is a 373 
complex task, as for HAZV there are a total of 28 aspartate residues that could potentially be 374 
cleaved, however we are struck by the high accessibility of the HAZV N protein to caspase 375 
digestion. Further work on this and other projects are currently underway, using the rescue 376 
system described here, and we hope that its use will accelerate further understanding of 377 
nairovirus molecular and cellular biology. 378 
 379 
MATERIALS AND METHODS 380 
 Cells and viruses. BSR-T7 cells (derived from baby hamster kidney, containing a T7 381 
polymerase expression gene) were maintained in Dulbecco’s modified Eagle medium (DMEM) 382 
(Sigma Aldrich) containing 2.5 % foetal bovine serum (FBS) (Invitrogen). SW13 cells (derived 383 
from human adrenal cortex) were maintained in DMEM containing 10 % FBS. All cell culture 384 
media were supplemented with 100 U/ml penicillin and 100 µg/ml streptomycin and grown at 385 
37 ¡C in a 5 % CO2 atmosphere. Tick-derived HAE/CTVM9 (Hyalomma anatolicum) cells [31] 386 
were maintained in L15 / MEM containing 20 % FBS, 10 % tryptose phosphate broth, 2 mM 387 
L-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin at 30 ¡C. 388 
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 389 
 Plasmids. Full-length cDNAs representing the S, M and L segments were synthesized 390 
(Genewiz) using the HAZV strain JC280 (Genebank accession numbers: M86624.1, 391 
NC_038710 and DQ076419.1, respectively) as reference and incorporated into the pMK-RQ 392 
plasmid, resulting in the generation of pMK-RQ-S, pMK-RQ-M and pMK-RQ-L, able to express 393 
S, M and L segment-specific RNAs, respectively. Viral gene segments were flanked by the 394 
bacteriophage T7 polymerase promoter, and hepatitis delta virus ribozyme to ensure correct 395 
formation of 3’ and 5’ terminal sequences, with the cDNAs orientated such that primary T7 396 
polymerase transcripts were of positive sense. pCAG-T7pol was a gift from Ian Wickersham 397 
(Addgene plasmid #59926). Generation of mutant plasmids was achieved using the Q5 Site 398 
Directed Mutagenesis (SDM) kit (New England Biolabs) according to the manufacturer’s 399 
instructions, with all mutant plasmid sequences confirmed via sequencing (Genewiz)  400 
 401 
 Virus rescue. Six-well plates were seeded with 2x105 BSR-T7 cells/well 1 day prior to 402 
transfection in 2 ml DMEM supplemented with 2.5 % FBS. 16-24 hours later, cells were 403 
transfected with 1.2 µg of pMK-RQ-S, pMK-RQ-M, pMK-RQ-L and 0.6 µg pCAG-T7pol, 404 
combined with 2.5 µl Mirus TransIT-LT1 transfection reagent (Mirus Bio) per µg of DNA in 200 405 
µl OPTI-MEM (Life Technologies). For mutant recovery, the WT plasmid was replaced with 406 
the corresponding mutant plasmid. A control sample was set up alongside each experiment 407 
in which transfection of pMK-RQ-L was omitted. Cell supernatants were collected 72-, 96- and 408 
120-hours post transfection and 300 µl supernatant was passaged in a 6-well plate of SW13 409 
cells grown in DMEM supplemented with 10 % FBS for 48 hours. 100 µl supernatant was also 410 
used to titre virus following transfection using a standard plaque assay protocol. 411 
 412 
 Virus infections. SW13 monolayers were infected with HAZV at the specified 413 
multiplicity of infection (MOI) in serum-free DMEM (SFM) at 37 ¡C. After 1 hour, the inoculum 414 
was removed and cells washed in phosphate buffered saline (PBS), fresh DMEM containing 415 
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2.5 % FBS, 100 U/ml penicillin and 100 µg/ml streptomycin was then applied for the duration 416 
of the infection. Infections of HAE/CTVM9 cells of tick origin were carried out at an MOI of 417 
0.01 in a similar manner to mammalian cell infections, but with an incubation temperature of 418 
30 ¡C. 419 
 420 
 Inhibition of caspases. SW13 monolayers were pre-treated with 20 µM Z-FA-FMK 421 
for 45 minutes in SFM at 37 ¡C prior to infection with HAZV at an MOI of 0.1. Following 422 
infection, virus and inhibitor were removed, cells were washed three times in PBS and 2.5% 423 
FBS DMEM was reapplied containing 20 µM Z-FA-FMK. At 24-, 32- and 48-hours timepoints 424 
total cell lysates were harvested and prepared for western blot. 425 
 426 
Cell viability assays. SW13 monolayers were pre-treated with a range of Z-FA-FMK 427 
concentrations for 1 hour 45 minutes in SFM, matching the duration of the pre-treatment and 428 
infection stage. At this point, media was changed to 2.5% FBS DMEM containing the same 429 
concentration of drug, again matching the infection procedure. Following a 48-hours infection 430 
period, cell viability was assessed using the CellTiter 96® AQueous One Solution Cell 431 
Proliferation Assay (Promega) according to the manufacturer’s instructions. 432 
 433 
 Western blotting. For preparation of cell lysates, monolayers were washed in ice cold 434 
PBS followed by incubation in ice cold RIPA buffer (150 mM sodium chloride, 1.0% NP-40 435 
alternative, 0.1% SDS, 50 mM Tris, pH 8.0) and agitated for 120 seconds. Cells were then 436 
harvested via cell scraping and transferred to pre-chilled Eppendorf tubes, after which lysates 437 
were centrifuged at 20,000 x g for 15 minutes to pellet insoluble material. SDS-gel loading 438 
buffer containing DTT was added to the supernatant prior to storage at -20oC. Proteins were 439 
separated on 12 % SDS polyacrylamide gels by electrophoresis and transferred to 440 
fluorescence compatible PVDF (FL-PVDF) membranes. Sheep anti-HAZV-N antiserum 441 
generated as previously described [32] was used to detect HAZV-N, and was subsequently 442 
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visualised using fluorescently labelled anti-sheep secondary antibodies. Membranes were 443 
visualised on the LiCor Odyssey Sa Infrared imaging system. 444 
 445 
 Virus titration. Determination of virus titre for construction of growth curves was 446 
achieved through plaque assay. Briefly, SW13 cells were seeded (2x106) into 75 cm2 flasks 447 
24 hours prior to infection with HAZV, rHAZV or mutant rHAZV at an MOI of 0.001. 448 
Supernatant was collected at time points of 24-, 48-, 72-, 96- and 120-hours post infection, 449 
and serially-diluted to infect fresh monolayers of SW13 cells in a 6-well plate. Following 450 
infection, media containing virus was removed and replaced with 1:1 2.5 % FBS DMEM and 451 
1.6 % methylcellulose and returned to incubate for a further 6 days prior to fixing and staining 452 
with crystal violet. Plaques were then counted and virus titre determined. 453 
 454 
 Extraction of viral RNA. Viral RNA was first extracted from cell-free supernatant using 455 
the QIamp Viral RNA kit (Qiagen) and treated with DNase to remove any contaminating DNA 456 
before a cDNA copy was generated using ProtoScript II Reverse Transcriptase (New England 457 
Biolabs) according to manufacturer’s instructions. PCR amplification of an »800 bp fragment 458 
using primers specific to the HAZV S segment was achieved using the Q5 High Fidelity 459 
Polymerase (New England Biolabs). Restriction digest analysis was performed by incubating 460 
Hind III (New England Biolabs) with 500 ng PCR product at 37 ¡C for 1 hour prior to resolving 461 
DNA bands on a 1 % agarose gel containing 0.01 % SYBR Safe (ThermoFisher). 462 
  463 
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FIGURE LEGENDS 586 
 587 
Figure 1. Detection of multiple HAZV-N cleavage products. A) Monolayers of SW13 cells 588 
were infected with HAZV at an MOI of 0.01. At the indicated hour time points post infection 589 
(hpi), total cell lysates were collected and analysed for HAZV-N expression by western blotting 590 
with HAZV-N antiserum. B) Predicted cleavage motifs of HAZV-N and associated predicted 591 
molecular weights of N’ and C’ fragments resulting from cleavage in Daltons. C) Schematic 592 
showing solvent-accessible location of motifs described in part B. 593 
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595 
Figure 2. Recovery of recombinant HAZV. A) Schematic showing work-flow for recovery of 596 
rHAZV. Plasmids were transfected into BSR-T7 cells for the indicated duration, prior to harvest 597 
of supernatant and subsequent 48-hour infection of SW13 monolayers. B) Detection of HAZV-598 
N protein post transfection (p.Tr) of BSR-T7 cells and subsequent 48 hour post infections 599 
(p.Inf). Supernatant samples collected from transfected BSR-T7 cells at 72-, 96- and 120- 600 
hours post transfection (hpt) were used to infect monolayers of SW13 cells. Following a 48-601 
hour infection, lysates were collected (p.Inf, lanes 2-4) and analysed for N expression by 602 
western blotting alongside lysates collected from the initial transfected BSR-T7 cells (p.Tr, 603 
lane 1). Recovery of wild-type (WT) rHAZV (Complete) was carried out alongside a control 604 
recovery omitting transfection of the essential pMK-RQ-L plasmid (p.Tr and p.Inf, lanes 5-8). 605 
Detection of GAPDH abundance was included as a loading control. C) Titre of infectious 606 
rHAZV released into supernatant at 72-, 96-, and 120-hour time points p.Tr was assessed via 607 
plaque assay, error bars represent average of two repeats. 608 
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 610 
Figure 3. Growth kinetics of rHAZV versus parental isolate, A) Titre of infectious rHAZV 611 
(circle) and its parental strain of HAZV (square) harvested at 24-hour intervals for 4 days 612 
following infection of SW13 cells at an MOI of 0.001. B) Representative plaque assays used 613 
to determine titre of infectious HAZV and rHAZV in (A) showing plaque morphology to be 614 
similar in both instances. Serial dilutions were generated from virus harvested 24 hours post 615 
infection and used to infect SW13 monolayers for 1 hour prior to addition of a methyl cellulose 616 
overlay. Cells were then fixed and stained 6 days post infection and viral plaques were 617 
counted.  618 
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 621 
Figure 4. Confirmation of cDNA origin via recovery of mutant rHAZV. A) Table outlining 622 
the change (underlined) to both cDNA sequence of the HAZV-N ORF and the resulting amino 623 
acid sequence. B) Detection of HAZV-N by western blotting following transfection (p.Tr) of 624 
BSR-T7 cells and subsequent 48 hour infections (p.Inf). Supernatant samples collected from 625 
transfected BSR-T7 cells at 96 hours p.Tr were used to infect monolayers of SW13 cells. 626 
Following a 48-hour infection, lysates were collected and analysed by western blotting for N 627 
expression. Recovery of rHAZV containing a Hind III restriction site (rHAZV-G723T) was 628 
carried out alongside a complete and control recovery of rHAZV. Detection of GAPDH 629 
abundance was included as a loading control. C) Schematic showing the location of the 630 
inserted Hind III restriction site into the S-segment ORF cDNA. D) Restriction digest of dsDNA 631 
fragment following RNA extraction of rHAZV and rHAZV-G723T containing supernatants, first 632 
strand synthesis and PCR amplification of viral genetic material. 633 
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 635 
 636 
Figure 5. Recovery of mutant rHAZV targeting multiple caspase motifs. A) Schematic 637 
showing location of caspase cleavage motifs on the apex of the arm domains for HAZV and 638 
CCHFV, with amino acid positions indicated numerically. B) Western blot detection of HAZV-639 
N protein for rHAZV-DQVE, ENKE and AQVA mutants following transfection (p.Tr) of BSR-T7 640 
cells and subsequent 48 hour infections (p.Inf) of SW13 cells using supernatant harvested 72-641 
, 96- and 120-hours p.Tr. Recovery of all mutants was carried out alongside independent 642 
complete and control recoveries of WT rHAZV. Detection of GAPDH abundance was included 643 
as a loading control. C) Representative plaque assays from supernatant taken 120 hours p.Tr 644 
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displaying plaque morphology for recovered viruses. D) Titre of infectious WT rHAZV (circle) 645 
versus DQVE (triangle¯) and ENKE (triangle­) at 24-hour intervals following infection of SW13 646 
cells at an MOI of 0.001. E) Detection of HAZV-N and associated cleavage products at 30 and 647 
32 kDa (*) and 20 kDa (**) following a 48-hour infection at an MOI of 0.01. 648 
 649 
 650 
Figure 6. The ability of rHAZV, rHAZV-DQVE and rHAZV ENKE to replicate in the tick cell line 651 
HAE/CTVM9 was examined via western blot detection of HAZV-N in lysates taken 48 hours 652 
post infection (hpi) at an MOI of 0.01. Actin was included as a loading control. 653 
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